Acupuncture Treatment for Improving Alzheimer's Dementia
NCT04064021 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2022-10-12
Summary
Evaluate cognitive improvement pre amd post acupuncture treatment in patients with probable alzheimer's dementia as measured by MOCA score and also per form A( measure of patient's personal information). Also caregiver input.
Conditions
- Cognitive Deficits
- Alzheimer Disease
Interventions
- PROCEDURE
-
Acupunture
Patient will receive 12 acupuncture treatments over 6 weeks (2x per week)
Sponsors & Collaborators
-
N & S Neurology Center, A Medical Group, Inc
lead INDUSTRY
Principal Investigators
-
SANJAY CHAUHAN, M.D. · N & S Neurology Center, A Medical Group, Inc
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 60 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2026-12-31
- Completion
- 2027-03-31
More Related Trials
-
Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease
NCT00469456 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
NCT06619613 ·Status: RECRUITING ·Phase: PHASE1
-
4Hz Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease
NCT04088643 ·Status: UNKNOWN ·Phase: NA
-
MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)
NCT00420420 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
NCT01125631 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
NCT06721156 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Feasibility Study of Transcranial Ultrasound Stimulation on Alzheimer's Disease Patients
NCT03896698 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)
NCT05602727 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of HellenCare in Early-Stage Alzheimer's Disease
NCT06895525 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Efficacy of MT-4666
NCT01764243 ·Status: COMPLETED ·Phase: PHASE2
-
Alzheimer's Disease Treated With Vagus Nerve Stimulation
NCT06923007 ·Status: RECRUITING ·Phase: NA
-
A Study of NH280105 in Healthy Adult Participants
NCT06870058 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)
NCT05466422 ·Status: COMPLETED ·Phase: PHASE1
-
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
NCT03538522 ·Status: COMPLETED ·Phase: PHASE2
-
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
NCT00495820 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
NCT05681819 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
NCT05040217 ·Status: RECRUITING ·Phase: PHASE1
-
Electrophysiologic Measures of Treatment Response in Alzheimer Disease
NCT00018278 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD
NCT04931459 ·Status: COMPLETED ·Phase: PHASE1
-
Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)
NCT00074529 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)
NCT00874939 ·Status: TERMINATED ·Phase: PHASE1
-
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
NCT06304883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Multicenter Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease
NCT04137926 ·Status: UNKNOWN ·Phase: NA
-
A Phase 3 Study of NE3107 in Probable Alzheimer's Disease
NCT04669028 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
NCT00105547 ·Status: COMPLETED ·Phase: PHASE3